KNTE - Xoma to acquire Kinnate Biopharma for $2.3352 - $2.5879 per share
2024-02-16 08:23:48 ET
XOMA Corporation ( NASDAQ: XOMA ), a company focused on biopharma royalties, announced an agreement on Friday to acquire clinical-stage biotech Kinnate Biopharma ( NASDAQ: KNTE ) for $2.3352–$2.5879 per share in cash plus a contingent value right....
Xoma to acquire Kinnate Biopharma for $2.3352 - $2.5879 per share